General Information of the Compound
Compound ID
CP0541037
Compound Name
5-(4-chlorophenyl)-2-quinazolin-4-yl-1,2,4-triazol-3-amine
    Show/Hide
Structure
Formula
C16H11ClN6
Molecular Weight
322.759
Canonical SMILES
Nc1nc(nn1-c1ncnc2ccccc12)-c1ccc(Cl)cc1
    Show/Hide
InChI
InChI=1S/C16H11ClN6/c17-11-7-5-10(6-8-11)14-21-16(18)23(22-14)15-12-3-1-2-4-13(12)19-9-20-15/h1-9H,(H2,18,21,22)
    Show/Hide
InChIKey
VVTWSKWCTKZCGO-UHFFFAOYSA-N
Physicochemical Property
logP
3.1131
Rotatable Bonds
2
Heavy Atom Count
23
Polar Areas
82.51
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 127042476
ChEMBL ID
CHEMBL3763978
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01902, Serine-protein kinase ATM
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000083 MCF-7 Homo sapiens (Human)  1
1
IC50 > 40000 nM
   TI
   LI
   LO
   TS